Skip to content

HighTide Therapeutics Inc Sustainability Reports

HighTide Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing multi-targeted therapies for the treatment of chronic metabolic and digestive diseases.

Sector: Manufacturing

Country: China

Exchange: Hong Kong Stock Exchange

FIGI: BBG00L42CZV9

4 reports from 2023 to 2025